These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6298169)

  • 21. The inhibition of beta-lactamases from gram-negative bacteria by clavulanic acid.
    Reading C; Farmer T
    Biochem J; 1981 Dec; 199(3):779-87. PubMed ID: 7041890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity and beta-lactamase stability of N-formimidoyl thienamycin compared to that of second and third generation cephalosporins.
    Vuye A
    Chemotherapy; 1982; 28(4):267-75. PubMed ID: 6981493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic activity of mecillinam in combination with the beta-lactamase inhibitors clavulanic acid and sulbactam.
    Neu HC
    Antimicrob Agents Chemother; 1982 Sep; 22(3):518-9. PubMed ID: 6291454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacteriological investigations with beta-lactamase inhibitors.
    Ullmann U
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):222-9. PubMed ID: 6289565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-lactamase inactivation by mechanism-based reagents.
    Fisher J; Belasco JG; Charnas RL; Khosla S; Knowles JR
    Philos Trans R Soc Lond B Biol Sci; 1980 May; 289(1036):309-19. PubMed ID: 6109326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cefoxitin resistance by a chromosomal cephalosporinase in Escherichia coli.
    Takahashi I; Sawai T; Ando T; Yamagishi S
    J Antibiot (Tokyo); 1980 Sep; 33(9):1037-42. PubMed ID: 7002896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chromosomal beta-lactamase expression and resistance to beta-lactam antibiotics in Proteus vulgaris and Morganella morganii.
    Yang YJ; Livermore DM
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1385-91. PubMed ID: 3058021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of beta-lactamase inhibitors on beta-lactamases from anaerobic bacteria.
    Hedberg M; Lindqvist L; Tunér K; Nord CE
    Eur J Clin Microbiol Infect Dis; 1992 Nov; 11(11):1100-4. PubMed ID: 1338315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A kinetic study of NMC-A beta-lactamase, an Ambler class A carbapenemase also hydrolyzing cephamycins.
    Mariotte-Boyer S; Nicolas-Chanoine MH; Labia R
    FEMS Microbiol Lett; 1996 Sep; 143(1):29-33. PubMed ID: 8807798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Properties of a cephalosporinase produced by Proteus penneri inhibited by clavulanic acid].
    Miro E; Barthelemy M; Peduzzi J; Reynaud A; Morand A; Prats G; Labia R
    Pathol Biol (Paris); 1994 May; 42(5):487-90. PubMed ID: 7824319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Properties of cephalosporinase from Proteus morganii.
    Toda M; Inoue M; Mitsuhashi S
    J Antibiot (Tokyo); 1981 Nov; 34(11):1469-75. PubMed ID: 6976340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic activity of piperacillin in combination with beta-lactamase inhibitors.
    Neu HC; Fu KP
    Antimicrob Agents Chemother; 1980 Oct; 18(4):582-5. PubMed ID: 6255862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of clavulanic acid, sulbactam and tazobactam on three different beta-lactamases from Bacteroides uniformis, Clostridium butyricum and Fusobacterium nucleatum.
    Hedberg M; Lindqvist L; Tunér K; Nord CE
    J Antimicrob Chemother; 1992 Jul; 30(1):17-25. PubMed ID: 1331018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of N-formimidoyl thienamycin (MK0787) on beta-lactamases and activity against beta-lactamase-producing strains.
    Toda M; Sato K; Nakazawa H; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1980 Nov; 18(5):837-8. PubMed ID: 6969580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conversion of cloxacillin into a progressive inhibitor of beta-lactamases by sulfonation and its activity against various types of these enzymes.
    Yamaguchi A; Adachi A; Hirata T; Adachi H; Sawai T
    J Antibiot (Tokyo); 1985 Jan; 38(1):83-93. PubMed ID: 3871761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-vitro antagonism by N-formimidoyl thienamycin and cefoxitin of second and third generation cephalosporins in Aeromonas hydrophila and Serratia marcescens.
    Miller MA; Finan M; Yousuf M
    J Antimicrob Chemother; 1983 Apr; 11(4):311-8. PubMed ID: 6343337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta-lactamase stability and inhibitory activity of meropenem combined with a potent antibacterial activity.
    Nouda H; Harabe ET; Sumita Y; Okuda T; Fukasawa M
    Chemotherapy; 1992; 38(4):218-24. PubMed ID: 1473360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial and beta-lactamase inhibitory activities of carpetimycins A and B, new carbapenem antibiotics.
    Kobayashi F; Saino Y; Koshi T; Hattori Y; Nakayama M; Iwasaki A; Mori T; Mitsuhashi S
    Antimicrob Agents Chemother; 1982 Apr; 21(4):536-44. PubMed ID: 6979308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imipenem (N-formimidoyl thienamycin): in vitro antimicrobial activity and beta-lactamase stability.
    Barry AL; Jones RN; Thornsberry C; Ayers LW; Kundargi R
    Diagn Microbiol Infect Dis; 1985 Mar; 3(2):93-104. PubMed ID: 3872196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative evaluation of a new beta-lactamase inhibitor, YTR 830, combined with different beta-lactam antibiotics against bacteria harboring known beta-lactamases.
    Gutmann L; Kitzis MD; Yamabe S; Acar JF
    Antimicrob Agents Chemother; 1986 May; 29(5):955-7. PubMed ID: 3015011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.